Caption Management, LLC Akebia Therapeutics, Inc. Transaction History

Caption Management, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 11, 2022	BUY	$2.26 - $3.34 $474,599 - $701,400	210,000 New	210,000 $475,000
Q3 2020 Nov 16, 2020	SELL	$2.39 - $13.08 $119,500 - $654,000	-50,000 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$6.67 - $13.58 $66,700 - $135,800	10,000 Added 25.0%	50,000 $678,000
Q1 2020 May 15, 2020	SELL	$4.1 - $10.24 $207,177 - $517,437	-50,531 Reduced 55.82%	40,000 $303,000
Q4 2019 Feb 13, 2020	BUY	$3.16 - $6.73 $53,817 - $114,618	17,031 Added 23.17%	90,531 $572,000
Q2 2019 Aug 13, 2019	BUY	$4.1 - $8.05 $276,750 - $543,375	67,500 Added 1125.0%	73,500 $356,000
Q1 2019 May 14, 2019	BUY	$5.41 - $8.73 $32,460 - $52,380	6,000 New	6,000 $49,000

127

56.5M

291K

179K

Ticker AKBA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 183,848,992
Market Cap $386M
Description
Akebia Therapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics for patients with kidney diseases. The company's lead product investigational product candidate is vadadustat, an oral therapy, which is in Phase III development for the treatment of anemia due to chronic kidney disease (CKD) ...

Get notified when there are updates to the investment portfolio of Caption Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Caption Management, LLC with notifications on news.